Eric R Goedken

Title: The Innovations of Eric R Goedken

Introduction

Eric R Goedken is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of tricyclic compounds. With a total of three patents to his name, Goedken's work focuses on innovative solutions for treating immunological and oncological conditions.

Latest Patents

Goedken's latest patents include advancements in tricyclic compounds. The first patent provides a compound of Formula (I) along with pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers thereof. These compounds are defined by specific variables and are designed to be useful in treating various immunological and oncological conditions. The second patent mirrors the first, emphasizing the same innovative compounds and their therapeutic applications.

Career Highlights

Eric R Goedken is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to focus on groundbreaking research and development in the pharmaceutical industry. Goedken's expertise and innovative mindset have positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Goedken has collaborated with notable colleagues, including Neil Wishart and Maria A Argiriadi. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in pharmaceutical research.

Conclusion

Eric R Goedken's contributions to the field of pharmaceuticals through his patents on tricyclic compounds highlight his commitment to addressing critical health challenges. His work continues to pave the way for new treatments in immunology and oncology, showcasing the importance of innovation in medicine.